Medicine and Dentistry
Liver Transplantation
100%
Liver Graft
22%
Liver Disease
21%
Liver Cirrhosis
20%
Hepatocellular Carcinoma
17%
Hepatitis C
14%
Health Care Cost
12%
Hepatitis C Virus
12%
Cohort Analysis
12%
Tacrolimus
11%
Recurrent Disease
11%
Kidney Transplantation
10%
Glomerular Filtration Rate
9%
Prevalence
9%
Diseases
9%
Overall Survival
8%
Haplotype
8%
Kidney Function
8%
Alcohol Consumption
8%
Immunosuppressive Treatment
7%
Fibrosis
7%
Primary Sclerosing Cholangitis
7%
Hepatitis Virus
6%
End Stage Liver Disease
6%
Budd-Chiari Syndrome
6%
Acute Graft Rejection
6%
Acute Kidney Injury
6%
Proteinuria
6%
Biological Marker
6%
Acute Liver Failure
5%
Hemochromatosis
5%
Drug Withdrawal
5%
Sorafenib
5%
Cyclosporine
5%
Patient Selection
5%
Amyloidosis
5%
Systemic Disease
5%
Disease Burden
5%
Sickle-Cell Disease
5%
Intensive Care Unit
5%
Human Immunodeficiency Virus
5%
Heart Arrest
5%
Fibrinogen
5%
Janus Kinase 2
5%
Stomach Mucosa
5%
Rituximab
5%
Inflammatory Bowel Disease
5%
Model For End Stage Liver Disease Score
5%
Liver Fibrosis
5%
Randomized Controlled Trial
5%
Nursing and Health Professions
Liver Transplantation
28%
Acute Liver Failure
11%
Intensive Care Unit
11%
Liver Graft
9%
Liver Cell Carcinoma
8%
Graft Survival
7%
Tylenol
7%
Graft Failure
7%
Acute Kidney Failure
6%
Fibrosis
5%
Liver Fibrosis
5%
Organ Transplantation
5%
Ferritin Blood Level
5%
Clinical Practice
5%
Model For End Stage Liver Disease Score
5%
Hepatitis C
5%
Ferritin
5%
Graft Rejection
5%
Recurrent Disease
5%
Heart Arrest
5%
Liver Toxicity
5%
Patient Selection
5%
Combination Therapy
5%
Kidney Transplantation
5%
Sorafenib
5%
Pharmacology, Toxicology and Pharmaceutical Science
End Stage Liver Disease
12%
Liver Cell Carcinoma
11%
Recurrent Disease
11%
microRNA
11%
Paracetamol
9%
Liver Disease
8%
Acute Liver Failure
8%
Graft Failure
7%
Fibrosis
7%
Hepatotoxicity
7%
Hepatitis C Virus
6%
Hepatitis C
6%
Combination Therapy
5%
Cohort Study
5%
Central Nervous System Aspergillosis
5%
Alcohol Liver Disease
5%
Graft Rejection
5%
Sorafenib
5%
Hemochromatosis
5%
Liver Fibrosis
5%
Acute Kidney Failure
5%
Voriconazole
5%
Tacrolimus
5%
Acute Graft Rejection
5%
Ciclosporin
5%
Randomized Controlled Trial
5%
